CD8A and acute myeloid leukemia: The TARGET-AML cohort showed substantial heterogeneity in overall T- and CD8+ T cell levels across all cytogenetic subgroups, with only nine out of 27 KMT2A-rearranged AML cases (33%) having high T cell infiltration (Fig. 1I, J).